Enhance your company’s visibility and amplify your life sciences brand internationally by sponsoring an MTPConnect event at BIO2026.
Read More
If your organisation is building, manufacturing or supplying medtech in Australia, apply to exhibit in the Showcase.
Read More
The title, ‘Ambitious Australia’, is an accurate reflection of our challenge – there’s no time to waste and boldness is the order of the day.
Read More
Find out more about the Australian–Swiss Joint Research Programme, a new funding opportunity jointly implemented by the Swiss National Science Foundation (SNSF) and the National Health and Medical Research Council (NHMRC).
Read More
Enhance your company’s visibility and amplify your life sciences brand internationally by sponsoring an MTPConnect event at BIO2026.
Read More
If your organisation is building, manufacturing or supplying medtech in Australia, apply to exhibit in the Showcase.
Read More
The title, ‘Ambitious Australia’, is an accurate reflection of our challenge – there’s no time to waste and boldness is the order of the day.
Read MoreWe wrapped up our visit to China, building connections with life sciences sector in Suzhou and Shanghai.
Read More
Registrations have opened for our next WAGES Grant workshop coming up in Perth – don’t miss out.
Read More
MTPConnect has taken part in a panel session at BIOCHINA in Suzhou!
Read More
Check out what MTPConnect got up to in February!
Read More
Join our March SA Insights event exploring how South Australia’s innovation infrastructure and places accelerate research translation and industry collaboration.
Read More
Bringing together senior hospital clinicians, procurement leaders and health system stakeholders to provide practical guidance to companies on procurement challenges.
Read More
In this webinar, find out more about the TTRA Devices Round 2 investment opportunity, providing up to $1 million to help eligible Australian start-ups, spin-outs and SMEs develop innovative preventative, diagnostic, therapeutic and/or disease management devices for cardiovascular disease and the complications of diabetes (type 1 and type 2).
Read More
Seven Victorian companies will be taking part in our sought after procurement-ready program
Read More